Novartis India Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 845.4 million compared to INR 801.7 million a year ago. Revenue was INR 1,065 million compared to INR 885.3 million a year ago. Net income was INR 265.7 million compared to INR 76.1 million a year ago. Basic earnings per share from continuing operations was INR 10.76 compared to INR 3.08 a year ago. Diluted earnings per share from continuing operations was INR 10.76 compared to INR 3.08 a year ago.
For the nine months, sales was INR 2,539 million compared to INR 3,026.1 million a year ago. Revenue was INR 3,051.6 million compared to INR 3,443.5 million a year ago. Net income was INR 705.1 million compared to INR 783.4 million a year ago. Basic earnings per share from continuing operations was INR 28.56 compared to INR 31.74 a year ago. Diluted earnings per share from continuing operations was INR 28.56 compared to INR 31.74 a year ago.